Clarityn

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:Antihero
gptkbp:approves gptkb:1993
gptkb:FDA
gptkbp:available_in liquid form
orally disintegrating tablet
chewable form
gptkbp:available_on gptkb:pharmaceuticals
gptkbp:average_temperature room temperature
gptkbp:clinical_trial Phase IV
Phase III
gptkbp:clinical_use treatment of chronic urticaria
treatment of allergic conjunctivitis
treatment of skin allergies
treatment of allergic rhinitis
treatment of hay fever
gptkbp:color gptkb:white
gptkbp:contraindication lactation
pregnancy category B
hypersensitivity to loratadine
gptkbp:dosage_form 10 mg once daily
10 mg tablet
10 mg orally disintegrating tablet
5 mg chewable tablet
5 mg/5 m L syrup
gptkbp:excretion urine
feces
gptkbp:form gptkb:tablet
gptkb:Sugar
https://www.w3.org/2000/01/rdf-schema#label Clarityn
gptkbp:ingredients gptkb:loratadine
gptkbp:interacts_with gptkb:beer
CYP2 D6 inhibitors
CYP3 A4 inhibitors
gptkbp:invention gptkb:2011
gptkbp:lifespan 8 hours
gptkbp:manufacturer gptkb:Bristol-Myers_Squibb
gptkbp:marketed_as gptkb:Clarinex
gptkb:Claritin
gptkb:Alavert
gptkbp:mechanism_of_action H1 receptor antagonist
gptkbp:metabolism liver
gptkbp:packaging gptkb:bottle
blister pack
gptkbp:previous_name gptkb:loratadine
gptkbp:related_to hay fever
perennial allergic rhinitis
seasonal allergic rhinitis
gptkbp:side_effect fatigue
headache
nausea
rash
drowsiness
dry mouth
anaphylaxis
thrombocytopenia
palpitations
elevated liver enzymes
gptkbp:taste gptkb:sweet
gptkbp:used_for allergy relief
gptkbp:bfsParent gptkb:Schering_AG
gptkbp:bfsLayer 6